Papuloerythroderma of Ofuji Associated with Elevated Varicella-zoster Virus Complement-fixing Antibody Titers Following BNT162b2 mRNA COVID-19 Vaccination

Papuloerythroderma of Ofuji Associated with Elevated Varicella-zoster Virus Complement-fixing Antibody Titers Following BNT162b2 mRNA COVID-19 Vaccination

Saved in:

Bibliographic Details
Main Author:	Masahiro Oka
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2025-04-01
Series:	Acta Dermato-Venereologica
Subjects:	papuloerythroderma of Ofuji varicella-zoster virus complement-fixing antibody titer Pfizer–BioNTech COVID-19 (BNT162b2) vaccine COVID-19 herpes zoster
Online Access:	https://medicaljournalssweden.se/actadv/article/view/42546
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Gut microbiota is associated with persistence of longer-term BNT162b2 vaccine immunogenicity
by: Ho Yu Ng, et al.
Published: (2025-02-01)

COVID-19 vaccination-related attendance at a pediatric emergency department in Singapore among 12- to 18-year old adolescents
by: Nicholas Beng Hui Ng, et al.
Published: (2022-11-01)

Efficacy of BNT162b2 and CoronaVac in patients diagnosed with COVID-19
by: Dogan Mustafa, et al.
Published: (2023-06-01)

BNT162b2 immunization-related myocarditis in adolescents and consequent hospitalization: Report from a medical center
by: Chen-Wei Yen, et al.
Published: (2023-11-01)

COVID-19 Vaccination Protects Skeletal Muscle Against Statin-Related Side Effects
by: Daria Schetz, et al.
Published: (2025-03-01)

Antibody Titer Against Varicella Zoster Virus and Recombinant Varicella Zoster Vaccine in Hemodialysis Patients: What We Know, What We Should Know
by: Francesca K. Martino, et al.
Published: (2025-04-01)

Improving BNT162b2 mRNA vaccine tolerability without efficacy loss by Pidotimod supplementation
by: Claudio Ucciferri, et al.
Published: (2022-02-01)

Eventos adversos por la vacuna COVID-19 Pfizer-BioNTech® en niños de 5-17años
by: María del Rocío Hernández-Morales, et al.
Published: (2024-12-01)

COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis
by: Angel Justiz-Vaillant, et al.
Published: (2025-01-01)

Löfgren’s Syndrome Following BNT162b2 mRNA COVID-19 Vaccination and Subsequent Plaque-type Cutaneous Sarcoidosis after its Resolution
by: Masahiro Oka, et al.
Published: (2025-06-01)

A Systematic Review of Vascular Injuries: A Review of Petechiae, Purpura, and Ecchymosis in Critical Situations Following COVID‐19 Vaccination
by: Yasamin Kalantari, et al.
Published: (2025-03-01)

Varicella Zoster Virus Infection and Pregnancy: An Optimal Management Approach
by: Ana Ion, et al.
Published: (2025-02-01)

Atypical polyneuropathy caused by varicella Zoster virus: Involvement of vestibulocochlear, glossopharyngeal and vagus nerves
by: Mafalda Silva Ferreira, et al.
Published: (2019-08-01)

Expanded spectrum of varicella disease and the need for vaccination in India
by: Padma Srikanth, et al.
Published: (2024-12-01)

Medium-term immunogenicity of three doses of BNT162b2 and CoronaVac in Hong Kong neuromuscular disease patients
by: Michael Kwan Leung Yu, et al.
Published: (2024-12-01)

Varicella Zoster vaccination in hemodialysis patients: The state of the art
by: Laura Gobbi, et al.
Published: (2023-12-01)

Breaking the cycle: considerations for a life-course vaccination strategy against varicella-zoster virus
by: Giacomo Casabona, et al.
Published: (2025-12-01)

A Response to: Letter to the Editor Regarding “Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination”
by: Timothy E. Albertson, et al.
Published: (2025-04-01)

Research Progress on Varicella-Zoster Virus Vaccines
by: Hongjing Liu, et al.
Published: (2025-07-01)

Effectiveness of the BNT162b2 and the CoronaVac vaccines and boosters in healthcare workers
by: Hazal Cansu Çulpan, et al.
Published: (2023-12-01)

Analysis of sero-epidemiological characteristics of varicella in healthy children in Wuxi, China
by: Lingling Wang, et al.
Published: (2024-12-01)

Postinfectious (Varicella Zoster) Myositis and Mixed Polyneuropathy
by: Arti Muley, et al.
Published: (2019-07-01)

Varicella pneumonia in an immunocompetent adult patient: Case report and review of the literature
by: Carlos Felipe Arias-Osorio, et al.
Published: (2024-01-01)

Waning effectiveness against COVID-19-related hospitalization, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case–control study
by: Vincent Ka Chun Yan, et al.
Published: (2023-12-01)

Effectiveness of homologous and heterologous BNT162b2 and CoronaVac booster vaccination against severe COVID-19 outcomes
by: Masliyana Husin, et al.
Published: (2025-01-01)

High SARS-CoV-2 antibody levels after three consecutive BNT162b2 booster vaccine doses in nursing home residents
by: Marloes I Hofstee, et al.
Published: (2025-01-01)

Letter to the Editor Regarding "Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination" by Albertson et al. 2024
by: Ivan Pourmir, et al.
Published: (2025-04-01)

Varicella with Delayed Hemiplegia
by: J Gordon Millichap
Published: (1990-10-01)

Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution
by: Andreina Baj, et al.
Published: (2021-01-01)

Varicella-zoster Virus Infections in Patients with Hospital-diagnosed Atopic Dermatitis
by: Sigrun A.J. Schmidt, et al.
Published: (2024-12-01)

Predictive value of blood routine-derived inflammation indexes for varicella-zoster virus meningitis in patients with acute herpes zoster
by: Yan Zhang, et al.
Published: (2025-06-01)

Seroprevalence of antibodies against varicella zoster virus across all age groups during the post-COVID-19 pandemic period in Chonburi Province, Thailand
by: Thanunrat Thongmee, et al.
Published: (2024-12-01)

Characterization of neutralizing versus binding antibody and T cell responses to varicella-zoster virus in the elderly
by: Suthee Mangmee, et al.
Published: (2025-04-01)

Zoster sine herpete in a patient with lymphoma
by: Takashi Shinha, et al.
Published: (2025-01-01)

Neurological manifistations of herpes zoster virus reactivation
by: A. M. Ryumin, et al.
Published: (2022-04-01)

Immunogenicity and safety of live attenuated and recombinant/inactivated varicella zoster vaccines in people living with HIV: A systematic review
by: Valentina Carta, et al.
Published: (2024-12-01)

Atypical Hemolytic Uremic Syndrome Associated with BNT162b2 mRNA COVID-19 Vaccine in a Kidney Transplant Recipient: A Case Report and Literature Review
by: Eleonora Francesca Pattonieri, et al.
Published: (2025-02-01)

Seroepidemiological survey of the population 10 years after the implementation of the varicella vaccine 2-dose immunization strategy
by: Quanjun Fang, et al.
Published: (2025-12-01)

Varicella-zoster virus vasculopathy: a rare complication of Ramsay Hunt Syndrome: a literature review
by: Di Wu, et al.
Published: (2025-06-01)

Update on Infection with Varicella-Zoster Virus in Children: A Narrative Review
by: Uwe Wollina, et al.
Published: (2025-01-01)